182 related articles for article (PubMed ID: 36325343)
1. Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis.
Moles L; Delgado S; Gorostidi-Aicua M; Sepúlveda L; Alberro A; Iparraguirre L; Suárez JA; Romarate L; Arruti M; Muñoz-Culla M; Castillo-Triviño T; Otaegui D;
Front Immunol; 2022; 13():960761. PubMed ID: 36325343
[TBL] [Abstract][Full Text] [Related]
2. Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis.
Zeng Q; Junli Gong ; Liu X; Chen C; Sun X; Li H; Zhou Y; Cui C; Wang Y; Yang Y; Wu A; Shu Y; Hu X; Lu Z; Zheng SG; Qiu W; Lu Y
Neurochem Int; 2019 Oct; 129():104468. PubMed ID: 31108132
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota and Derived Short-Chain Fatty Acids Are Linked to Evolution of Heart Failure Patients.
Modrego J; Ortega-Hernández A; Goirigolzarri J; Restrepo-Córdoba MA; Bäuerl C; Cortés-Macías E; Sánchez-González S; Esteban-Fernández A; Pérez-Villacastín J; Collado MC; Gómez-Garre D
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762194
[TBL] [Abstract][Full Text] [Related]
4. Short-chain fatty acids and gut microbiota in multiple sclerosis.
Melbye P; Olsson A; Hansen TH; Søndergaard HB; Bang Oturai A
Acta Neurol Scand; 2019 Mar; 139(3):208-219. PubMed ID: 30427062
[TBL] [Abstract][Full Text] [Related]
5. Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis.
Saresella M; Marventano I; Barone M; La Rosa F; Piancone F; Mendozzi L; d'Arma A; Rossi V; Pugnetti L; Roda G; Casagni E; Cas MD; Paroni R; Brigidi P; Turroni S; Clerici M
Front Immunol; 2020; 11():1390. PubMed ID: 32733460
[No Abstract] [Full Text] [Related]
6. The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis.
Barcutean L; Maier S; Burai-Patrascu M; Farczadi L; Balasa R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542172
[TBL] [Abstract][Full Text] [Related]
7. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors.
de la Cuesta-Zuluaga J; Mueller NT; Álvarez-Quintero R; Velásquez-Mejía EP; Sierra JA; Corrales-Agudelo V; Carmona JA; Abad JM; Escobar JS
Nutrients; 2018 Dec; 11(1):. PubMed ID: 30591685
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal Tract, Microbiota and Multiple Sclerosis (MS) and the Link Between Gut Microbiota and CNS.
Yousefi B; Babaeizad A; Banihashemian SZ; Feyzabadi ZK; Dadashpour M; Pahlevan D; Ghaffari H; Eslami M
Curr Microbiol; 2022 Dec; 80(1):38. PubMed ID: 36527519
[TBL] [Abstract][Full Text] [Related]
9. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes.
Tan C; Wu Q; Wang H; Gao X; Xu R; Cui Z; Zhu J; Zeng X; Zhou H; He Y; Yin J
JPEN J Parenter Enteral Nutr; 2021 Mar; 45(3):518-529. PubMed ID: 32473086
[TBL] [Abstract][Full Text] [Related]
10. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
11. Effects of ad libitum Free-Choice Access to Freshly Squeezed Domestic White Asparagus Juice on Intestinal Microbiota Composition and Universal Bio-Markers of Immuno-Metabolic Homeostasis and General Health in Middle-Aged Female and Male C57BL/6 Mice.
Ghadimi D; Frahm SO; Röcken C; Ebsen M; Schwiertz A; Fölster-Holst R; Bockelmann W; Heller KJ
Endocr Metab Immune Disord Drug Targets; 2022; 22(4):401-414. PubMed ID: 34463231
[TBL] [Abstract][Full Text] [Related]
12. Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls.
Olsson A; Gustavsen S; Nguyen TD; Nyman M; Langkilde AR; Hansen TH; Sellebjerg F; Oturai AB; Bach Søndergaard H
Front Immunol; 2021; 12():661493. PubMed ID: 34025661
[TBL] [Abstract][Full Text] [Related]
13. Short-chain fatty acids accompanying changes in the gut microbiome contribute to the development of hypertension in patients with preeclampsia.
Chang Y; Chen Y; Zhou Q; Wang C; Chen L; Di W; Zhang Y
Clin Sci (Lond); 2020 Jan; 134(2):289-302. PubMed ID: 31961431
[TBL] [Abstract][Full Text] [Related]
14. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Encephalitis: A Chinese Pilot Study.
Xu R; Tan C; He Y; Wu Q; Wang H; Yin J
Front Immunol; 2020; 11():1994. PubMed ID: 32973805
[TBL] [Abstract][Full Text] [Related]
15. Changes in Gut Microbiota and Multiple Sclerosis: A Systematic Review.
Ordoñez-Rodriguez A; Roman P; Rueda-Ruzafa L; Campos-Rios A; Cardona D
Int J Environ Res Public Health; 2023 Mar; 20(5):. PubMed ID: 36901634
[TBL] [Abstract][Full Text] [Related]
16. Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune Encephalomyelitis.
Calvo-Barreiro L; Eixarch H; Cornejo T; Costa C; Castillo M; Mestre L; Guaza C; Martínez-Cuesta MDC; Tanoue T; Honda K; González-López JJ; Montalban X; Espejo C
Neurotherapeutics; 2021 Apr; 18(2):920-937. PubMed ID: 33829410
[TBL] [Abstract][Full Text] [Related]
17. Role of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases.
Rasouli-Saravani A; Jahankhani K; Moradi S; Gorgani M; Shafaghat Z; Mirsanei Z; Mehmandar A; Mirzaei R
Biomed Pharmacother; 2023 Jun; 162():114620. PubMed ID: 37004324
[TBL] [Abstract][Full Text] [Related]
18. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study.
Boets E; Gomand SV; Deroover L; Preston T; Vermeulen K; De Preter V; Hamer HM; Van den Mooter G; De Vuyst L; Courtin CM; Annaert P; Delcour JA; Verbeke KA
J Physiol; 2017 Jan; 595(2):541-555. PubMed ID: 27510655
[TBL] [Abstract][Full Text] [Related]
19. Faecal microbiota from patients with cirrhosis has a low capacity to ferment non-digestible carbohydrates into short-chain fatty acids.
Jin M; Kalainy S; Baskota N; Chiang D; Deehan EC; McDougall C; Tandon P; Martínez I; Cervera C; Walter J; Abraldes JG
Liver Int; 2019 Aug; 39(8):1437-1447. PubMed ID: 30919578
[TBL] [Abstract][Full Text] [Related]
20. Impact of short-chain fatty acid supplementation on gut inflammation and microbiota composition in a murine colitis model.
Lee JG; Lee J; Lee AR; Jo SV; Park CH; Han DS; Eun CS
J Nutr Biochem; 2022 Mar; 101():108926. PubMed ID: 34848335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
